Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19
Clinical trial NCT04551547 · COMPLETED
Trial details
- NCT number
- NCT04551547
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-31
- Primary completion
- 2021-04-30
- Enrollment
- 552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.